GPRASP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.772600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.676600E-01
Normal-vs-Stage2
8.993200E-01
Normal-vs-Stage3
8.186000E-01
Normal-vs-Stage4
5.252800E-01
Stage1-vs-Stage2
2.032600E-01
Stage1-vs-Stage3
2.062200E-01
Stage1-vs-Stage4
4.505400E-01
Stage2-vs-Stage3
8.920800E-01
Stage2-vs-Stage4
2.008000E-01
Stage3-vs-Stage4
4.036800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.482800E-01
Normal-vs-AfricanAmerican
9.777600E-01
Normal-vs-Asian
3.944400E-01
Caucasian-vs-AfricanAmerican
3.210200E-01
Caucasian-vs-Asian
7.517800E-03
AfricanAmerican-vs-Asian
3.406800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.905600E-01
Normal-vs-Female
7.545400E-01
Male-vs-Female
9.753200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.188600E-01
Normal-vs-Age(41-60Yrs)
6.198800E-01
Normal-vs-Age(61-80Yrs)
8.568600E-01
Normal-vs-Age(81-100Yrs)
3.853000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.169600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.500800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.743000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.626000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.317000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.092400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.103800E-01
Normal-vs-Daily Drinker
9.488000E-01
Normal-vs-Weekly Drinker
7.765400E-01
Normal-vs-Occasional Drinker
5.995200E-01
Normal-vs-Social Drinker
5.910600E-01
Non Drinker-vs-Daily Drinker
3.508000E-01
Non Drinker-vs-Weekly Drinker
4.919400E-01
Non Drinker-vs-Occasional Drinker
9.430100E-02
Non Drinker-vs-Social Drinker
1.200610E-01
Daily Drinker-vs-Weekly Drinker
6.233400E-01
Daily Drinker-vs-Occasional Drinker
2.898800E-01
Daily Drinker-vs-Social Drinker
3.098200E-01
Weekly Drinker-vs-Occasional Drinker
1.540450E-01
Weekly Drinker-vs-Social Drinker
1.808970E-01
Occasional Drinker-vs-Social Drinker
9.734800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.086800E-01
Normal-vs-Grade 2
3.547400E-01
Normal-vs-Grade 3
3.227800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.829900E-02
Grade 1-vs-Grade 3
2.898000E-02
Grade 1-vs-Grade 4
4.086800E-01
Grade 2-vs-Grade 3
9.866000E-01
Grade 2-vs-Grade 4
3.547400E-01
Grade 3-vs-Grade 4
3.227800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.800800E-01
Normal-vs-NonDiabetic
7.613000E-01
Diabetic-vs-NonDiabetic
1.878430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.227400E-01
Normal-vs-NoPancreatitis
7.869600E-01
Pancreatitis-vs-NoPancreatitis
1.327670E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.298000E-01
Normal-vs-N1
9.796000E-01
N0-vs-N1
5.384300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.141800E-01
Normal-vs-TP53-NonMutant
2.717700E-02
TP53-Mutant-vs-TP53-NonMutant
3.157800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
